Methods for diagnosing and monitoring treatment ADHD by assessing the dopamine transporter level
US7553478B2 · kind B2 · utility
0Cited by
23References
15Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 18, 2006 |
| Grant date | Jun 30, 2009 |
| Priority date | — |
| Expiry date | Oct 10, 2026 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K51/0448
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of diagnosing attention deficient-hyperactivity disorder (ADHD) in a human patient by assessing the level of dopamine transporter in at least one region of the patient's central nervous system, where an elevated level of dopamine transporter in the patient is indicative of ADHD. In embodiments of the invention, assessment of dopamine transporter levels includes assessing binding of a dopamine transporter ligand to the dopamine transporters using PET or SPECT.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.